C4 Therapeutics (CCCC) Q3 2021 Earnings Report

700 Followers

CCCC Upcoming Earnings

C4 Therapeutics's next earnings date is estimated for February 25, 2027, based on past reporting schedules.

Q3 2021 Earnings Call Summary

No earnings call summary is available for this earnings event.

CCCC earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Feb 25, 2027	2026 (Q4)	-0.23-	-0.18	―	―
Nov 05, 2026	2026 (Q3)	-0.19-0.16	-0.44	63.64% (+0.28)
Aug 11, 2026	2026 (Q2)	-0.23-0.18	-0.37	51.35% (+0.19)
May 12, 2026	2026 (Q1)	-0.25-0.20	-0.37	45.95% (+0.17)
Feb 26, 2026	2025 (Q4)	-0.29-0.18	-0.49	63.27% (+0.31)
Nov 06, 2025	2025 (Q3)	-0.41-0.44	-0.35	-25.71% (-0.09)
Aug 07, 2025	2025 (Q2)	-0.38-0.37	-0.26	-42.31% (-0.11)
May 07, 2025	2025 (Q1)	-0.44-0.37	-0.41	9.76% (+0.04)
Feb 27, 2025	2024 (Q4)	-0.49-0.49	-0.68	27.94% (+0.19)
Oct 31, 2024	2024 (Q3)	-0.38-0.35	-0.55	36.36% (+0.20)
Aug 01, 2024	2024 (Q2)	-0.36-0.26	-0.73	64.38% (+0.47)
May 08, 2024	2024 (Q1)	-0.36-0.41	-0.71	42.25% (+0.30)
Feb 22, 2024	2023 (Q4)	-0.69-0.68	-0.76	10.53% (+0.08)
Nov 01, 2023	2023 (Q3)	-0.66-0.55	-0.65	15.38% (+0.10)
Aug 08, 2023	2023 (Q2)	-0.68-0.73	-0.56	-30.36% (-0.17)
May 04, 2023	2023 (Q1)	-0.75-0.71	-0.65	-9.23% (-0.06)
Feb 23, 2023	2022 (Q4)	-0.74-0.76	-0.31	-145.16% (-0.45)
Nov 03, 2022	2022 (Q3)	-0.71-0.65	-0.51	-27.45% (-0.14)
Aug 04, 2022	2022 (Q2)	-0.69-0.56	-0.51	-9.80% (-0.05)
May 05, 2022	2022 (Q1)	-0.62-0.65	-0.49	-32.65% (-0.16)
Feb 24, 2022	2021 (Q4)	-0.58-0.31	-0.27	-14.81% (-0.04)
Nov 10, 2021	2021 (Q3)	-0.57-0.51	-17.55	97.09% (+17.04)
Aug 11, 2021	2021 (Q2)	-0.59-0.51	-0.32	-60.38% (-0.19)
May 13, 2021	2021 (Q1)	―-0.49	-0.33	-50.31% (-0.16)
Nov 12, 2020	2020 (Q3)	―-17.55	-0.29	-6036.36% (-17.26)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed